aAndrew F. Alexis, MD, MPH; bFran Cook-Bolden, MD; cTina Lin, PharmD aDepartment of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, New York, New York bSkin Specialty Dermatology and Department of Dermatology, Mount Sinai Health Systems, New York, New York cValeant Pharmaceuticals North America LLC, Bridgewater, New Jersey Disclosure: Dr. Alexis is an Advisory … Continue reading Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A Post-hoc Analysis of the Efficacy and Tolerability of Clindamycin 1.2%/ Benzoyl Peroxide 3.75% Gel